Biomedical Engineering Reference
In-Depth Information
18. Knauer, M., Rutgers, E., Mook, S., Cardoso, F., Van de Vijver, M., Viale,
G., Glas, A., Saghatchian, M., Kok, M., Bueno-de-Mesquita, J. M., Linn,
S. C., and van 't Veer, L. J. (2009) The 70-gene MammaPrint signature
for optimal risk stratification in endocrine responsive breast cancer. In
11th International Conference Primary Therapy of Early Breast Cancer,
St Gallen Oncology Conferece
Vol. 18, Supplement 1 pp. S36, Abstract
0072, The Breast, St. Gallen, Switzerland.
19. Knauer, M., Straver, M. E., Rutgers, E., Bender, R., Cardoso, F., Mook, S.,
Van de Vijver, M., Saghatchian, M., Koornstra, R. H., Bueno-de-Mesquita,
J. M., Rodenhuis, S., Linn, S. C., and van 't Veer, L. J. (2009) The 70-gene
MammaPrint signature is predictive for chemotherapy benefit in early
breast cancer. In
11th International Conference Primary Therapy of
Early Breast Cancer, St Gallen Oncology Conference
Vol. 18, Supplement
1 pp. S36, Abstract 0073, The Breast, St. Gallen, Switzerland.
20. Kunz, G., Glas, A., De Snoo, F., and Simon, I. (2009) Use of the genomic
test MammaPrint in daily clinical practice to assist in risk stratification
of young breast cancer patients. In
11th International Conference
Primary Therapy of Early Breast Cancer, St Gallen Oncology Conference
Vol. 18, Supplement 1 pp. S37, Abstract 0075, The Breast, St. Gallen,
Switzerland.
21. M. Saghatchian, M., Mook, S., Pruneri, G., Viale, G., Glas, A., Eekhout,
I., Knauer, M., and van 't Veer, L. J. (2009) The 70-gene MammaPrint
profile allows to identify a subgroup of very good-prognostic patients
with primary breast cancer and 4-9 positive lymph nodes. In
11th
International Conference Primary Therapy of Early Breast Cancer, St
Gallen Oncology Conference
Vol. 18, Supplement 1 pp. S36, Abstract
0071, The Breast, St. Gallen, Switzerland.
22. Mayordomo, J. I., Roig, A. M., Rolfo, C. D., Morales, S., Glas, A., Floore, A.,
De Snoo, F., and Stork-Sloots, L. (2008) Feasibility of using core needle
biopsies for the 70-gene prognosis signature. In
Vol. 19 pp. viii77-viii88, Abstract 202P, Early Breast Cancer Session,
Abstract Book in Annals of Oncology, Stockholm, Sweden.
23. Mook, S., Knauer, M., Bueno-de-Mesquita, J. M., Retel, V. P., Wesseling, J.,
Linn, S. C., Van't Veer, L. J., and Rutgers, E. J. (2010) Metastatic potential
of T1 breast cancer can be predicted by the 70-gene MammaPrint
signature.
33rd ESMO Congress
17, 1406-1413.
24. Mook, S., Schmidt, M. K., Viale, G., Pruneri, G., Eekhout, I., Floore, A.,
Glas, A. M., Bogaerts, J., Cardoso, F., Piccart-Gebhart, M. J., Rutgers, E. T.,
and Van't Veer, L. J. (2009) The 70-gene prognosis-signature predicts
disease outcome in breast cancer patients with 1-3 positive lymph
Ann Surg Oncol
